Artificial pancreas improves nocturnal glucose control in children

02/27/2013 | PhysiciansBriefing.com

Youths with type 1 diabetes who used an artificial pancreas system had lower incidence of nocturnal hypoglycemia and better control of nocturnal glucose levels than those who used an insulin pump, an Israeli study showed. Researchers found no evidence of severe adverse reactions with the use of the artificial pancreas. The findings appear in the New England Journal of Medicine.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC